A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

IsraelRecruitingPHASE3

Conditions

Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Southern Cancer Center (SCC) ( Site 8000), Daphne, Alabama, United States

    Study coordinator · 251-607-5283
  • The University of Arizona Cancer Center - North Campus ( Site 0055), Tucson, Arizona, United States

    Study coordinator · 520-626-0191
  • Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles, California, United States

    Study coordinator · 626-627-6666
  • Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach, California, United States

    Study coordinator · 949-764-5501
  • St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado ( Site 0021), Grand Junction, Colorado, United States

    Study coordinator · 970-298-7638
  • Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark, Delaware, United States

    Study coordinator · 302-366-1200
  • Comprehensive Hematology Oncology ( Site 0060), St. Petersburg, Florida, United States

    Study coordinator · 727-344-6569
  • Baptist Health Lexington ( Site 0050), Lexington, Kentucky, United States

    Study coordinator · 859-509-3044
  • Baptist Health Hamburg ( Site 0071), Lexington, Kentucky, United States

    Study coordinator · 859-639-7827
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack, New Jersey, United States

    Study coordinator · 551-996-5900
  • Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick, New Jersey, United States

    Study coordinator · 732-235-2465
  • Presbyterian Kaseman Hospital ( Site 0072), Albuquerque, New Mexico, United States

    Study coordinator · 505-925-0405
  • University of New Mexico Comprehensive Cancer Center ( Site 0047), Albuquerque, New Mexico, United States

    Study coordinator · 505-272-4946
  • Presbyterian Rust Jorgensen Cancer ( Site 0073), Rio Rancho, New Mexico, United States

    Study coordinator · 505-253-7878
  • Queens Hospital Cancer Center ( Site 0011), Jamaica, New York, United States

    Study coordinator · 718-883-4133
  • Optum Medical Care, PC ( Site 0009), Westbury, New York, United States

    Study coordinator · 516-488-2918
  • Novant Health Cancer Institute ( Site 0019), Charlotte, North Carolina, United States

    Study coordinator · 980-302-6500
  • Novant Health Oncology Specialists ( Site 0074), Winston-Salem, North Carolina, United States

    Study coordinator · 336-277-8800
  • TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati, Ohio, United States

    Study coordinator · 513-865-9460
  • University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh, Pennsylvania, United States

    Study coordinator · 412-641-6500
  • Cancer Care Associates Of York ( Site 0063), York, Pennsylvania, United States

    Study coordinator · 717-741-9229
  • SCRI Oncology Partners ( Site 7000), Nashville, Tennessee, United States

    Study coordinator · 615-329-7274
  • Tennessee Oncology, PLLC ( Site 0068), Nashville, Tennessee, United States

    Study coordinator · 615-320-5090
  • Texas Oncology - DFW ( Site 8003), Dallas, Texas, United States

    Study coordinator · 214-370-1794
  • JPS Health Network ( Site 0067), Fort Worth, Texas, United States

    Study coordinator · 817-702-8049
  • Texas Oncology - Gulf Coast ( Site 8006), Houston, Texas, United States

    Study coordinator · 713-467-1722
  • Oncology Consultants P.A. ( Site 0061), Houston, Texas, United States

    Study coordinator · 713-516-4968
  • Texas Oncology - Central/South Texas ( Site 8005), McAllen, Texas, United States

    Study coordinator · 956-687-5150
  • Mays Cancer Center ( Site 0049), San Antonio, Texas, United States

    Study coordinator · 210-450-3838
  • Virginia Oncology Associates (VOA) ( Site 8001), Norfolk, Virginia, United States

    Study coordinator · 757-368-5033
  • Shenandoah Oncology ( Site 8004), Winchester, Virginia, United States

    Study coordinator · 540-662-1108
  • Northwest Medical Specialties, PLLC ( Site 0062), Tacoma, Washington, United States

    Study coordinator · 253-841-4296
  • Circuit Clinical/SSM Health Dean Medical Group ( Site 0039), Madison, Wisconsin, United States

    Study coordinator · 608-355-2033
  • Hospital Aleman ( Site 0200), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +541148277000X2306
  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0205), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +542234963224
  • Fundación Respirar ( Site 0201), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541170781548
  • Centro Privado de RMI Rio Cuarto ( Site 0207), Río Cuarto, Córdoba Province, Argentina

    Study coordinator · +543584620273
  • Instituto de Oncología de Rosario ( Site 0208), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414218909
  • Instituto Alexander Fleming ( Site 0202), CABA, Argentina

    Study coordinator · +541132218900
  • Hospital Italiano de Córdoba ( Site 0206), Córdoba, Argentina

    Study coordinator · +543514106500
  • Blacktown Hospital-Blacktown Cancer and Haematology Centre - Medical Oncology ( Site 2300), Blacktown, New South Wales, Australia

    Study coordinator · 02 8670 5077
  • Chris O'Brien Lifehouse ( Site 2302), Camperdown, New South Wales, Australia

    Study coordinator · +61 2 85140922
  • Monash Medical Centre ( Site 2301), Clayton, Victoria, Australia

    Study coordinator · +61 3 85722941
  • The Alfred Hospital ( Site 2305), Melbourne, Victoria, Australia

    Study coordinator · 03 9076 2000
  • Hospital de Câncer de Recife ( Site 0302), Recife, Pernambuco, Brazil

    Study coordinator · +558132178084
  • Liga Norte Riograndense Contra o Câncer ( Site 0301), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +558440095595
  • Hospital do Câncer Mãe de Deus ( Site 0300), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555132344345
  • Instituto de Oncologia Saint Gallen ( Site 0308), Santa Cruz do Sul, Rio Grande do Sul, Brazil

    Study coordinator · +555130568686
  • ANIMI - Unidade de Tratamento Oncologico ( Site 0306), Lages, Santa Catarina, Brazil

    Study coordinator · +554933805220
  • Hospital Paulistano ( Site 0304), São Paulo, Brazil

    Study coordinator · +5511944716385
  • The Moncton Hospital ( Site 0101), Moncton, New Brunswick, Canada

    Study coordinator · 5068575756
  • Sunnybrook Research Institute ( Site 0105), Toronto, Ontario, Canada

    Study coordinator · 416-480-5248
  • CIDO SpA ( Site 0408), Temuco, Araucania, Chile

    Study coordinator · 56934016366
  • FALP ( Site 0400), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224205098
  • Oncovida ( Site 0402), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56225992900
  • Centro de Oncología de Precisión ( Site 0410), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56225189885
  • Clínica MEDS La Dehesa ( Site 0405), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224996400
  • Bradfordhill ( Site 0401), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970
  • Anhui Provincial Cancer Hospital ( Site 3140), Hefei, Anhui, China

    Study coordinator · 0551-65327666
  • Cancer Hospital Chinese Academy of Medical Sciences ( Site 3100), Beijing, Beijing Municipality, China

  • Peking University People's Hospital ( Site 3138), Beijing, Beijing Municipality, China

    Study coordinator · 010-88326666
  • The First Affiliated Hospital of Chongqing Medical University ( Site 3101), Chongqing, Chongqing Municipality, China

    Study coordinator · 02389011515
  • Chongqing Three Gorges Central Hospital's ( Site 3128), Wanzhou, Chongqing Municipality, China

    Study coordinator · 02358103238
  • The First Affiliated hospital of Xiamen University ( Site 3120), Fujian, Fujian, China

    Study coordinator · 0592-2137327
  • Sun Yat-Sen University Cancer Center ( Site 3102), Guangzhou, Guangdong, China

    Study coordinator · 020-87342479
  • Jiangmen Central Hospital ( Site 3132), Jiangmen, Guangdong, China

    Study coordinator · 0750-3989521
  • Guangxi Medical University Affiliated Tumor Hospital ( Site 3118), Nanning, Guangxi, China

    Study coordinator · 0771-5331955
  • Henan Cancer Hospital ( Site 3108), Zhengzhou, Henan, China

    Study coordinator · 0371-65588007
  • Xiangyang Central Hospital ( Site 3123), Xiangyang, Hubei, China

    Study coordinator · +8607102810910
  • Hunan Cancer Hospital ( Site 3134), Changsha, Hunan, China

    Study coordinator · 0731-89762160
  • Jiangsu Cancer Hospital ( Site 3107), Nanjing, Jiangsu, China

    Study coordinator · +8602583283415
  • Jiangsu Province Hospital ( Site 3105), Nanjing, Jiangsu, China

    Study coordinator · 02568308145
  • Nanchang People's Hospital ( Site 3124), Nanchang, Jiangxi, China

    Study coordinator · 0791-86728121
  • Xi'an International Medical Center Hospital ( Site 3122), Xi'an, Shaanxi, China

    Study coordinator · 02968302436
  • Affiliated Cancer Hospital of Shandong First Medical University ( Site 3115), Jinan, Shandong, China

    Study coordinator · 0531-67626073
  • Sichuan Cancer Hospital. ( Site 3110), Chengdu, Sichuan, China

    Study coordinator · 02885420509
  • West China Hospital of Sichuan University ( Site 3139), Chengdu, Sichuan, China

    Study coordinator · 028-85422114
  • Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3112), Ürümqi, Xinjiang, China

    Study coordinator · +8609917819133
  • Sir Run Run Shaw Hospital ( Site 3117), Hangzhou, Zhejiang, China

    Study coordinator · +8657186960497
  • Zhejiang Cancer Hospital ( Site 3109), Hangzhou, Zhejiang, China

    Study coordinator · 0571-88122072
  • Taizhou Hospital of Zhejiang Province ( Site 3137), Linhai, Zhejiang, China

    Study coordinator · +86 0516 85120120
  • Instituto de Cancerología-Oncology ( Site 0503), Medellín, Antioquia, Colombia

    Study coordinator · +573043826133
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0502), Bogotá, Bogota D.C., Colombia

    Study coordinator · (+57) 3183662238
  • Instituto Nacional De Cancerologia ( Site 0504), Bogotá, Bogota D.C., Colombia

    Study coordinator · +57 3004224753
  • Sociedad De Oncología y Hematología Del Cesar SAS ( Site 0501), Valledupar, Cesar Department, Colombia

    Study coordinator · +5755602310
  • IMAT S.A.S ( Site 0500), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +57 300 2152346
  • CHRU de Brest ( Site 0904), Brest, Finistere, France

    Study coordinator · +33298233987
  • CENTRE LEON BERARD ( Site 0900), Lyon, Rhone, France

    Study coordinator · +33478782654
  • Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen ( Site 0901), Rouen, Seine-Maritime, France

    Study coordinator · +33232082220
  • Gustave Roussy ( Site 0903), Villejuif, Val-de-Marne, France

    Study coordinator · +33142116162
  • Klinikum Lippe Detmold ( Site 1008), Detmold, North Rhine-Westphalia, Germany

    Study coordinator · +49 5231 720
  • Klinikum Dortmund Klinikzentrum Mitte ( Site 1005), Dortmund, North Rhine-Westphalia, Germany

    Study coordinator · +4923195320733
  • Universitaetsklinikum des Saarlandes-Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedi ( Site 1003), Homburg, Saarland, Germany

    Study coordinator · +4968411628127
  • General Hospital of Athens "Laiko" ( Site 1105), Athens, Attica, Greece

    Study coordinator · 0030 2132060954
  • Aretaieio Hospital ( Site 1103), Athens, Attica, Greece

    Study coordinator · +302107286444
  • University General Hospital of Heraklion ( Site 1102), Heraklion, Irakleio, Greece

    Study coordinator · +302810392091
  • European Interbalkan Medical Center-Oncology Department ( Site 1101), Thessaloniki, Greece

    Study coordinator · 0030 2310400213
  • Prince of Wales Hospital ( Site 3301), Hong Kong, Hong Kong

    Study coordinator · +852 3505 1138
  • Queen Mary Hospital ( Site 3300), Pokfulam, Hong Kong

    Study coordinator · 39103339
  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1200), Kecskemét, Bács-Kiskun county, Hungary

    Study coordinator · +3676516719
  • Szabolcs Szatmár Bereg Vármegyei Oktatókórház Oncoradiology ( Site 1203), Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

    Study coordinator · +3642599700
  • Rambam Health Care Campus ( Site 1401), Haifa, Israel

    Study coordinator · 972-4-7776234
  • Shaare Zedek Medical Center ( Site 1406), Jerusalem, Israel

    Study coordinator · 972-2-6555768
  • Hadassah Medical Center ( Site 1404), Jerusalem, Israel

    Study coordinator · 972-2-6777111
  • Sheba Medical Center ( Site 1400), Ramat Gan, Israel

    Study coordinator · 972-3-5304436
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1507), Bergamo, Lombardy, Italy

    Study coordinator · +390352674366
  • Istituto Europeo di Oncologia IRCCS ( Site 1508), Milan, Lombardy, Italy

    Study coordinator · +390257490439
  • Ospedale San Raffaele. ( Site 1502), Milan, Italy

    Study coordinator · +390226436530
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1501), Milan, Italy

    Study coordinator · +390223902849
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Clinica Sperimentale di Senologia ( Site 1506), Naples, Italy

    Study coordinator · +39 08117770442
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1500), Roma, Italy

    Study coordinator · 00390630157337
  • Aichi Cancer Center ( Site 3200), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111
  • Nagoya City University Hospital ( Site 3210), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-858-7215
  • National Hospital Organization Hokkaido Cancer Center ( Site 3215), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-811-9111
  • Mie University Hospital ( Site 3216), Tsu, Mie-ken, Japan

    Study coordinator · +81-59-231-5246
  • Kansai Medical University Hospital ( Site 3213), Hirakata, Osaka, Japan

    Study coordinator · +81-72-804-0101
  • Kindai University Hospital ( Site 3204), Sakai, Osaka, Japan

    Study coordinator · +81-72-366-0221
  • Shizuoka Cancer Center ( Site 3202), Sunto-gun, Shizuoka, Japan

    Study coordinator · +81-55-989-5222
  • National Cancer Center Hospital ( Site 3206), Chūō, Tokyo, Japan

    Study coordinator · +81-3-3542-2511
  • Toranomon Hospital ( Site 3205), Minato, Tokyo, Japan

    Study coordinator · +81-3-3588-1111
  • Showa Medical University Hospital ( Site 3209), Shinagawa, Tokyo, Japan

    Study coordinator · +81-3-3784-8000
  • Akita University Hospital ( Site 3207), Akita, Japan

    Study coordinator · +81-18-834-1111
  • Chiba Cancer Center ( Site 3203), Chiba, Japan

    Study coordinator · +81-43-264-5431
  • National Hospital Organization Kyushu Cancer Center ( Site 3208), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 3212), Fukushima, Japan

    Study coordinator · +81-24-547-1111
  • Hiroshima City Hiroshima Citizens Hospital ( Site 3214), Hiroshima, Japan

    Study coordinator · +81-82-221-2291
  • National Hospital Organization Osaka National Hospital ( Site 3201), Osaka, Japan

    Study coordinator · +81-6-6942-1331
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0600), Guadalajara, Jalisco, Mexico

    Study coordinator · +52 3330447001
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0604), Monterrey, Nuevo León, Mexico

    Study coordinator · +528183338111
  • Cuidados Oncologicos. ( Site 0605), Querétaro City, Querétaro, Mexico

    Study coordinator · +52 4422428555
  • Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0602), Chihuahua City, Mexico

    Study coordinator · +526144559270
  • Centro de Investigacion Clinica de Oaxaca ( Site 0601), Oaxaca City, Mexico

    Study coordinator · +52 9516035559
  • Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 0702), Concepción, Departamento de Junín, Peru

    Study coordinator · +51958864658
  • Clínica Internacional - Sede San Borja ( Site 0704), San Borja, Lima region, Peru

    Study coordinator · 516196100
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0701), San Isidro, Lima region, Peru

    Study coordinator · 512241598
  • Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1618), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · +48523743344
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 1600), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462522
  • Bialostockie Centrum Onkologii ( Site 1604), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48856646888
  • Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oncologii, Chemioterapii ( Site 1616), Słupsk, Pomeranian Voivodeship, Poland

    Study coordinator · +48598460390
  • Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 1614), Olsztyn, Warmian-Masurian Voivodeship, Poland

    Study coordinator · 48895398610
  • Szpital Wojewodzki im.M.Kopernika. ( Site 1607), Koszalin, West Pomeranian Voivodeship, Poland

    Study coordinator · +48943488400
  • Salve Medica sp. z o.o. sp. k. ( Site 1615), Lodz, Łódź Voivodeship, Poland

    Study coordinator · +48422546440
  • Seoul National University Bundang Hospital ( Site 2703), Seongnam, Kyonggi-do, South Korea

    Study coordinator · +82317877384
  • Gangnam Severance Hospital, Yonsei University Health System ( Site 2701), Gangnam-gu, Seoul, South Korea

    Study coordinator · +82220193305
  • Samsung Medical Center ( Site 2704), Gangnam-gu, Seoul, South Korea

    Study coordinator · +82234101780
  • Seoul National University Hospital ( Site 2702), Jongno-Gu, Seoul, South Korea

    Study coordinator · +82220720850
  • Severance Hospital Yonsei University Health System ( Site 2700), Seoul, South Korea

    Study coordinator · +82222288135
  • Asan Medical Center ( Site 2705), Seoul, South Korea

    Study coordinator · +82230103217
  • Institut Català d'Oncologia (ICO) - Badalona ( Site 1823), Badalona, Barcelona, Spain

    Study coordinator · +34934978925
  • Hospital Universitario Marques de Valdecilla ( Site 1825), Santander, Cantabria, Spain

    Study coordinator · 942212100 ext 73351
  • CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1820), A Coruña, La Coruna, Spain

    Study coordinator · +34981178000
  • Hospital Clinic de Barcelona ( Site 1821), Barcelona, Spain

    Study coordinator · +34932275400
  • Hospital Universitario Ramon y Cajal ( Site 1824), Madrid, Spain

    Study coordinator · 913368263
  • Hospital Clinico San Carlos... ( Site 1822), Madrid, Spain

    Study coordinator · +34913303000 484816
  • Hospital Universitario Virgen de Valme ( Site 1826), Seville, Spain

    Study coordinator · 955015273
  • Ditmanson Medical Foundation Chia-Yi Christian Hospital ( Site 2806), Chiayi City, Chiayi, Taiwan

    Study coordinator · +88652765041x3190
  • Taichung Veterans General Hospital ( Site 2803), Taichung, Taiwan

    Study coordinator · +886423592525x5031
  • National Cheng Kung University Hospital ( Site 2804), Tainan, Taiwan

    Study coordinator · +88662353535x6729
  • Chi-Mei Medical Center ( Site 2805), Tainan, Taiwan

    Study coordinator · +88662812811x53571
  • National Taiwan University Hospital ( Site 2800), Taipei, Taiwan

    Study coordinator · +886905051082
  • MacKay Memorial Hospital ( Site 2802), Taipei, Taiwan

    Study coordinator · +886975835311
  • National Taiwan University Cancer Center (NTUCC) ( Site 2801), Taipei, Taiwan

    Study coordinator · +886905051082
  • Faculty of Medicine Siriraj Hospital ( Site 2921), Bangkoknoi, Bangkok, Thailand

    Study coordinator · +6624141914
  • Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2924), Dusit, Bangkok, Thailand

    Study coordinator · +6622443461
  • Ramathibodi Hospital. ( Site 2923), Ratchathewi, Bangkok, Thailand

    Study coordinator · +6622011672
  • Songklanagarind Hospital ( Site 2922), Hat Yai, Changwat Songkhla, Thailand

    Study coordinator · +6674451469
  • Maharaj Nakorn Chiang Mai Hospital ( Site 2925), Muang, Chiang Mai, Thailand

    Study coordinator · +6653935533
  • Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2107), Adana, Turkey (Türkiye)

    Study coordinator · +905353067506
  • Hacettepe Universite Hastaneleri ( Site 2100), Ankara, Turkey (Türkiye)

    Study coordinator · +903123052935
  • Memorial Ankara Hastanesi ( Site 2106), Ankara, Turkey (Türkiye)

    Study coordinator · +903122536622
  • Gazi University Health Research and Application Center Gazi Hospital ( Site 2101), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 202 44 44
  • Ankara Bilkent Şehir Hastanesi ( Site 2105), Ankara, Turkey (Türkiye)

    Study coordinator · +903125526000
  • Dicle Üniversitesi ( Site 2102), Diyarbakır, Turkey (Türkiye)

    Study coordinator · +90 412 248 80 01
  • Koç Üniversitesi Hastanesi ( Site 2104), Istanbul, Turkey (Türkiye)

    Study coordinator · 08502508250
  • Mersin Sehir Eğitim ve Araştırma Hastanesi ( Site 2103), Mersin, Turkey (Türkiye)

    Study coordinator · +903247517411
  • Recep Tayyip Erdogan University Training and Research Hospital ( Site 2108), Rize, Turkey (Türkiye)

    Study coordinator · +905069939926
  • Samsun Medical Park Hastanesi ( Site 2109), Samsun, Turkey (Türkiye)

    Study coordinator · +90 362 311 40 40
  • University College London Hospital ( Site 2206), London, England, United Kingdom

    Study coordinator · +442034472930
  • St Bartholomew s Hospital ( Site 2200), London, London, City of, United Kingdom

    Study coordinator · +442073777000
  • Leicester Royal Infirmary ( Site 2205), Leicester, United Kingdom

    Study coordinator · +44116 258 6295
  • The Christie NHS Foundation Trust ( Site 2208), Manchester, United Kingdom

    Study coordinator · +441614463000
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC